Stockreport

Coya Therapeutics Announces $5 Million Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)

Coya Therapeutics, Inc.  (COYA) 
PDF Funds will help support the development of COYA 302 for the treatment of Frontotemporal Dementia (FTD)COYA 302’s combination therapeutic approach aligns with ADDF’s beli [Read more]